366 related articles for article (PubMed ID: 2415744)
1. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
Thomson DM; Halliday WJ; Phelan K
J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
[TBL] [Abstract][Full Text] [Related]
2. T8 and T3 surface glycoproteins in human T-cell mediation of leukocyte adherence inhibition to extracts of autologous cancer.
Labateya N; Thomson DM
J Natl Cancer Inst; 1985 Dec; 75(6):987-94. PubMed ID: 2999497
[TBL] [Abstract][Full Text] [Related]
3. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
Shenouda G; Thomson DM
Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
[TBL] [Abstract][Full Text] [Related]
4. Recognition of a purified Mr-40,000 organ-specific immunogen of human lung cancer by class II-restricted T-cells.
Thomson DM; Sutherland M; Scanzano R; Shenouda G
J Natl Cancer Inst; 1987 Oct; 79(4):653-61. PubMed ID: 2443737
[TBL] [Abstract][Full Text] [Related]
5. Extraction of human organ-specific cancer neoantigens from cancer cells and plasma membranes with 1-butanol.
Labateya N; Thomson DM; Durko M; Shenouda G; Robb L; Scanzano R
Cancer Res; 1987 Feb; 47(4):1058-64. PubMed ID: 3100029
[TBL] [Abstract][Full Text] [Related]
6. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
Shenouda G; Thomson DM; MacFarlane JK
Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
[TBL] [Abstract][Full Text] [Related]
7. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
Geppert TD; Lipsky PE
J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
9. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
Platsoucas CD
Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific suppressor T lymphocytes in man make use of the same set of surface molecules as do cytolytic T lymphocytes: roles of Leu-2/T8, Leu-4/T3, Leu-5/T11, LFA-1 molecules.
Damle NK; Fishwild DM; Engleman EG
J Immunol; 1985 Sep; 135(3):1724-30. PubMed ID: 3160777
[TBL] [Abstract][Full Text] [Related]
11. Presentation of autoantigen by human T cells.
LaSalle JM; Ota K; Hafler DA
J Immunol; 1991 Aug; 147(3):774-80. PubMed ID: 1713605
[TBL] [Abstract][Full Text] [Related]
12. Distinction of naive and memory BoCD4 lymphocytes in calves with a monoclonal antibody, CC76, to a restricted determinant of the bovine leukocyte-common antigen, CD45.
Howard CJ; Sopp P; Parsons KR; McKeever DJ; Taracha EL; Jones BV; MacHugh ND; Morrison WI
Eur J Immunol; 1991 Sep; 21(9):2219-26. PubMed ID: 1716214
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte subsets differentially induce class II human leukocyte antigens on allogeneic microvascular endothelial cells.
Pardi R; Bender JR; Engleman EG
J Immunol; 1987 Oct; 139(8):2585-92. PubMed ID: 3116086
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
Mannie MD; Morrison-Plummer J; McConnell TJ
J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
[TBL] [Abstract][Full Text] [Related]
15. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
16. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation.
De Felice M; Turco MC; Giarrusso PC; Corbo L; Pizzano R; Martinelli V; Ferrone S; Venuta S
J Immunol; 1987 Oct; 139(8):2683-9. PubMed ID: 2443568
[TBL] [Abstract][Full Text] [Related]
17. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
Owens T; Fazekas de St Groth B
J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
[TBL] [Abstract][Full Text] [Related]
18. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens.
Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G
Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874
[TBL] [Abstract][Full Text] [Related]
19. Surface molecules involved in self-recognition and T cell activation in the autologous mixed lymphocyte reaction.
Romain PL; Schlossman SF; Reinherz EL
J Immunol; 1984 Sep; 133(3):1093-100. PubMed ID: 6235279
[TBL] [Abstract][Full Text] [Related]
20. Human T lymphocyte proliferation induced by a pan-T monoclonal antibody (anti-Leu 4): heterogeneity of response is a function of monocytes.
Kaneoka H; Perez-Rojas G; Sasasuki T; Benike CJ; Engleman EG
J Immunol; 1983 Jul; 131(1):158-64. PubMed ID: 6408167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]